Advertisement

Ophthalmologic health status of an aging population—data from the Berlin Aging Study II (BASE-II)

  • Richard BergholzEmail author
  • Ralf Michael Dutescu
  • Elisabeth Steinhagen-Thiessen
  • Adrian Rosada
Medical Ophthalmology
  • 25 Downloads

Abstract

Purpose

Vision of the elderly may be affected by typical age-related diseases like cataract and macular degeneration. Little is known about the effect of aging on visual difficulties and vision-related quality of life. This study was conducted to compare the ophthalmological health status of younger and older individuals within a large cohort study of residents of a greater metropolitan area (Berlin Aging Study II [BASE-II]).

Methods

A total of 1655 participants (805 men) aged 60 years and older and 494 participants (232 men) aged between 22 and 48 years from the Berlin Aging Study II were included in the analysis. The subjects were examined during a 2-day clinical examination period. History of ocular diseases, vision-related quality of life using the visual function questionnaire (VFQ- 25), refraction, distance and near visual acuity, tonometry, and color vision were provided.

Results

Older subjects performed significantly worse concerning distance and near visual acuity, color vision, and vision-related quality of life compared to young subjects. Intraocular pressure showed no significant difference between groups. Individuals are often unaware of existing eye diseases.

Conclusion

The prevalence of ocular diseases and the impairment of vision increases with age. Although 98% of elderly subjects have reported to suffer from any ocular disease, subjective quality of life seems to be affected to a lesser extent.

Keywords

BASE-II Vision-related quality of life Cross-sectional Age-related ophthalmological health 

Notes

Funding

The BASE-II research project is supported by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) and the Max Planck Institute for Human Development (MPIHD), Berlin.

Compliance with ethical standards

Conflict of interest

Richard Bergholz has received a travel grant by Allergan.

Ralf Michael Dutescu has received speaker’s honoraria for presentations by Ursapharm und Horus Pharma.

Elisabeth Steinhagen-Thiessen has received honoraria for presentations, advisory board activities, or data monitoring committee activities by Abbott, Aegerion, Amgen, Astra-Zeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Fresenius, Genzyme, Kaneka, Merck Sharp & Dohme, Novartis, Roche.

Adrian Rosada has received speakers’ honoraria for presentations and advisory board activities by Fresenius and B. Braun.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

All participants gave written informed consent and the Ethics Committee of the Charité – Universitätsmedizin Berlin approved the study (approval number EA2/029/09).

References

  1. 1.
    Bertram L, Bockenhoff A, Demuth I, Duzel S, Eckardt R, Li SC et al (2014) Cohort profile: the Berlin Aging Study II (BASE-II). Int.J.Epidemiol. 43:703–712CrossRefGoogle Scholar
  2. 2.
    Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD (2001) Development of the 25-item National Eye Institute visual function questionnaire. Arch.Ophthalmol. 119:1050–1058CrossRefGoogle Scholar
  3. 3.
    Velhagen K (1964) Tafeln zur Prüfung des Farbensinns, 23rd edn. Thieme Verlag, StuttgartGoogle Scholar
  4. 4.
    Lustig SP, Cappelleri JC, Chisholm JA, Getter CA, Pleil AM, Reichel MB (2004) Validity and reliability of the German version of the 25–item National Eye Institute visual function questionnaire in patients with age–related macular degeneration. Invest OphthalmolVisSci 45:1373Google Scholar
  5. 5.
    On-line Document: R development Core team (2016)R: a language and environment for statistical computing. Version 32.5. https://www.r-project.org. Accessed 1 Jan 2018
  6. 6.
    Klein BE, Klein R, Jensen SC (1994) Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology 101:1173–1177CrossRefGoogle Scholar
  7. 7.
    Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081–2090CrossRefGoogle Scholar
  8. 8.
    Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J et al (1992) Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 99:1499–1504CrossRefGoogle Scholar
  9. 9.
    Wong TY, Klein BE, Klein R, Knudtson M, Lee KE (2003) Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology 110:211–217CrossRefGoogle Scholar
  10. 10.
    Linton KL, Klein BE, Klein R (1991) The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye study. Am.J.Epidemiol. 134:1438–1446CrossRefGoogle Scholar
  11. 11.
    Wang Q, Klein BE, Klein R, Moss SE (1994) Refractive status in the Beaver Dam Eye study. Invest OphthalmolVisSci 35:4344–4347Google Scholar
  12. 12.
    Attebo K, Ivers RQ, Mitchell P (1999) Refractive errors in an older population: the Blue Mountains eye study. Ophthalmology 106:1066–1072CrossRefGoogle Scholar
  13. 13.
    Zocher MT, Rozema JJ, Oertel N, Dawczynski J, Wiedemann P, Rauscher FG (2016) Biometry and visual function of a healthy cohort in Leipzig, Germany. BMC.Ophthalmol. 16:79CrossRefGoogle Scholar
  14. 14.
    Lee KE, Klein BE, Klein R, Wong TY (2002) Changes in refraction over 10 years in an adult population: the Beaver Dam Eye study. Invest OphthalmolVisSci 43:2566–2571Google Scholar
  15. 15.
    Klein R, Klein BE, Linton KL, De Mets DL (1991) The Beaver Dam Eye study: visual acuity. Ophthalmology 98:1310–1315CrossRefGoogle Scholar
  16. 16.
    Klein R, Klein BE, Lee KE (1996) Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology 103:1169–1178CrossRefGoogle Scholar
  17. 17.
    Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F et al (2017) TFOS DEWS II epidemiology report. Ocul.Surf. 15:334–365CrossRefGoogle Scholar
  18. 18.
    Klein BE, Klein R, Linton KL (1992) Intraocular pressure in an American community. The Beaver Dam Eye study. Invest OphthalmolVisSci 33:2224–2228Google Scholar
  19. 19.
    Tan S, Yu M, Baig N, Hansapinyo L, Tham CC (2017) Agreement of patient-measured intraocular pressure using rebound tonometry with Goldmann applanation tonometry (GAT) in glaucoma patients. Sci.Rep. 7:42067CrossRefGoogle Scholar
  20. 20.
    Eraslan M, Cerman E, Summen S (2017) Comparison of intraocular pressure measurements in healthy pediatric patients using three types of tonometers. Turk.J.Ophthalmol. 47:1–4CrossRefGoogle Scholar
  21. 21.
    Kim NR, Kim CY, Kim H, Seong GJ, Lee ES (2011) Comparison of goldmann applanation tonometer, noncontact tonometer, and TonoPen XL for intraocular pressure measurement in different types of glaucomatous, ocular hypertensive, and normal eyes. Curr Eye Res 36:295–300CrossRefGoogle Scholar
  22. 22.
    Graham PA (1972) Epidemiology of simple glaucoma and ocular hypertension. Br.J.Ophthalmol. 56:223–229CrossRefGoogle Scholar
  23. 23.
    Hollows FC, Graham PA (1966) Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br.J.Ophthalmol. 50:570–586CrossRefGoogle Scholar
  24. 24.
    Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA et al (1980) The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv.Ophthalmol 24:335–610CrossRefGoogle Scholar
  25. 25.
    Rubin GS, West SK, Munoz B, Bandeen-Roche K, Zeger S, Schein O et al (1997) A comprehensive assessment of visual impairment in a population of older Americans. The SEE study. Salisbury eye evaluation project. Invest OphthalmolVisSci 38:557–568Google Scholar
  26. 26.
    Varma R, Wang MY, Ying-Lai M, Donofrio J, Azen SP (2008) The prevalence and risk indicators of uncorrected refractive error and unmet refractive need in Latinos: the Los AngelesLatino eye study. Invest OphthalmolVisSci 49:5264–5273CrossRefGoogle Scholar
  27. 27.
    Klein R, Lee KE, Gangnon RE, Klein BE (2013) Incidence of visual impairment over a 20-year period: the Beaver Dam Eye study. Ophthalmology 120:1210–1219CrossRefGoogle Scholar
  28. 28.
    Attebo K, Mitchell P, Smith W (1996) Visual acuity and the causes of visual loss in Australia. The Blue Mountains eye study. Ophthalmology 103:357–364CrossRefGoogle Scholar
  29. 29.
    Nucci C, Cedrone C, Culasso F, Ricci F, Cesareo M, Corsi A et al (2005) Incidence of visual loss in the Ponza eye study, Italy. Eye (Lond) 19:175–182CrossRefGoogle Scholar
  30. 30.
    Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam study. Arch.Ophthalmol. 116:653–658CrossRefGoogle Scholar
  31. 31.
    Reidy A, Minassian DC, Vafidis G, Joseph J, Farrow S, Wu J et al (1998) Prevalence of serious eye disease and visual impairment in a North London population: population based, cross sectional study. BMJ 316:1643–1646CrossRefGoogle Scholar
  32. 32.
    Liang YB, Friedman DS, Wong TY, Wang FH, Duan XR, Yang XH et al (2009) Rationale, design, methodology, and baseline data of a population-based study in rural China: the Handan eye study. Ophthalmic Epidemiol 16:115–127CrossRefGoogle Scholar
  33. 33.
    Dandona R, Dandona L, Naduvilath TJ, Nanda A, McCarty CA (1997) Design of a population-based study of visual impairment in India: the Andhra Pradesh eye disease study. Indian JOphthalmol 45:251–257Google Scholar
  34. 34.
    Chirambo MC, Tielsch JM, West KP Jr, Katz J, Tizazu T, Schwab L et al (1986) Blindness and visual impairment in southern Malawi. Bull World Health Organ 64:567–572Google Scholar
  35. 35.
    Hyman L, Wu SY, Connell AM, Schachat A, Nemesure B, Hennis A et al (2001) Prevalence and causes of visual impairment in the Barbados eye study. Ophthalmology 108:1751–1756CrossRefGoogle Scholar
  36. 36.
    Zerihun N, Mabey D (1997) Blindness and low vision in Jimma zone, Ethopia: results of a population-based survey. Ophthalmic Epidemiol 4:19–26CrossRefGoogle Scholar
  37. 37.
    Krumpaszky HG, Ludtke R, Mickler A, Klauss V, Selbmann HK (1999) Blindness incidence in Germany. A population-based study from Wurttemberg-Hohenzollern. Ophthalmologica 213:176–182CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Ophthalmology, Campus Virchow-KlinikumCharité – Universitätsmedizin BerlinBerlinGermany
  2. 2.ACTO e.V., An-InstituteRWTH Aachen UniversityAachenGermany
  3. 3.Department of Endocrinology and Metabolic DiseasesCharité - Universitätsmedizin BerlinBerlinGermany
  4. 4.Department of GeriatricsCharité – Universitätsmedizin BerlinBerlinGermany

Personalised recommendations